Nov 13 (Reuters) -
SHIN NIPPON BIOMEDICAL LABORATORIES LTD
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 10.33 9.53 19.60
(+8.4 pct) (+0.3%)
Operating 579 mln 556 mln 300 mln
(+4.1 pct) (-35.3%)
Recurring 313 mln 654 mln 190 mln
(-52.1 pct) (-14.3%)
Net 578 mln 164 mln 30 mln
(+251.7 pct)
EPS Y17.39 Y4.80 Y0.90
Annual div Y3.00 Y3.00
-Q2 div nil nil
-Q4 div Y3.00 Y3.00
NOTE - Shin Nippon Biomedical Laboratories Ltd provides clinical trial and other support services for drug development.
For latest earnings estimates made by Toyo Keizai, please
double click on 2395.TK1.
Healthcare